RASPANTI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 1.965
EU - Europa 1.396
AS - Asia 302
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 3.667
Nazione #
US - Stati Uniti d'America 1.959
PL - Polonia 391
RU - Federazione Russa 377
SE - Svezia 217
IE - Irlanda 130
IT - Italia 94
SG - Singapore 87
DE - Germania 53
HK - Hong Kong 48
CN - Cina 46
VN - Vietnam 40
JO - Giordania 34
FI - Finlandia 32
UA - Ucraina 27
IN - India 23
GB - Regno Unito 22
AT - Austria 20
TR - Turchia 19
BE - Belgio 11
CH - Svizzera 11
CA - Canada 6
FR - Francia 3
KR - Corea 3
LT - Lituania 3
NL - Olanda 2
AL - Albania 1
CI - Costa d'Avorio 1
EU - Europa 1
GR - Grecia 1
IL - Israele 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
Totale 3.667
Città #
Santa Clara 447
Warsaw 390
Chandler 205
Fairfield 201
Dublin 130
Woodbridge 108
Ashburn 91
Seattle 87
Cambridge 86
Ann Arbor 78
Jacksonville 78
Wilmington 76
Singapore 71
Houston 70
Dong Ket 40
Florence 35
Princeton 32
Lawrence 29
Hong Kong 25
Boardman 23
Altamura 22
Medford 22
Vienna 20
Izmir 18
Mumbai 18
Buffalo 17
Beijing 15
Shanghai 14
Kent 13
Bern 11
Boston 11
Brussels 11
San Diego 10
Moscow 9
Falls Church 8
New York 8
Sesto Fiorentino 7
Yubileyny 7
Los Angeles 6
Norwalk 6
Auburn Hills 4
Toronto 4
West Jordan 4
Fairfax 3
Frankfurt Am Main 3
Milan 3
Phoenix 3
Seoul 3
Venice 3
Andover 2
Bremen 2
Grosseto 2
Hillsboro 2
London 2
Miami 2
Padova 2
Pune 2
Abidjan 1
Arnsberg 1
Auckland 1
Bengaluru 1
Cantagallo 1
Changteh 1
Chengdu 1
Chicago 1
Colombo 1
Frankfurt am Main 1
Grevenbroich 1
Guangzhou 1
Helsinki 1
Hounslow 1
Kilburn 1
Laurel 1
Lima 1
Lisbon 1
Lodz 1
Mcallen 1
Montemurlo 1
Montréal 1
Munich 1
Napoli 1
New Kensington 1
Ottawa 1
Redmond 1
Romola 1
Saint Petersburg 1
Scandicci 1
Thessaloníki 1
Tirana 1
Turku 1
Verona 1
Washington 1
Xi'an 1
Totale 2.637
Nome #
3-Aza-6,8-dioxabicyclo[3.2.1]octanes as new enantiopure heteroatom-rich tropane-like ligands of human dopamine transporter. 308
¹²⁵I-radiolabeled morpholine-containing arginine-glycine-aspartate (RGD) ligand of αvβ₃ integrin as a molecular imaging probe for angiogenesis. 271
Relationship of sustained brain natriuretic peptide release after reperfused acute myocardial infarction with gated SPECT infarct measurements and its connection with collagen turnover and left ventricular remodeling. 239
1,2,3-triazole-based peptidomimetic integrin inhibitors for the diagnosis and therapy of tumors 182
Matrix metalloproteinases and their tissue inhibitor after reperfused ST-elevation myocardial infarction treated with doxycycline. Insights from the TIPTOP trial 131
Role of Side-Chain Bioisosteres in Determining the Binding Affinity of Click Chemistry Derived RGD Peptidomimetics to αvβ3 Integrin 126
A place for free radicals in platelet-derived histamine releasing factor (PDHRF) and evidence that histaminergic receptors modulate platelet aggregation. 125
Intact PTH vs. the whole PTH assay in uremic samples 124
Histamine release from rat mast cells induced by the metabolic activation of drugs of abuse into free radicals. 122
Click-chemistry-derived triazole ligands of arginine−glycine−aspartate (RGD) integrins with a broad capacity to inhibit adhesion of melanoma cells and both in vitro and in vivo angiogenesis 122
Kinetics Analysis of Parathyroid Hormone During Parathyroidectomy in the Assessment of Curative Surgery 119
Radiosynthesis and micro-SPECT analysis of triazole-based RGD integrin ligands as non-peptide molecular imaging probes for angiogenesis 117
Definition of platelet-derived histamine-releasing factor and histaminergic receptors modulating platelet aggregation. 116
Early short-term doxycycline therapy in patients with acute myocardial infarction and left ventricular dysfunction to prevent the ominous progression to adverse remodelling: the TIPTOP trial. 115
The role of histamine in platelet aggregation by physiological and immunological stimuli 113
Storage and release of histamine in human platelets. 112
Combination of click chemistry and sulfonamides to develop three-armed triazole compounds 110
Morpholine-based RGD-cyclopentapeptides as alphavbeta3/alphavbeta5 integrin ligands: role of configuration towards receptor binding affinity. 108
False serum calcitonin high levels using a non-competitive two-site IRMA. 107
Discovery of sub-nanomolar RGD-based alphavbeta3/alphavbeta5 integrin binders embedding 4-aminoproline residues 106
Nitric oxide modulates cardiac and mast cell anaphylaxis. 99
Platelet aggregation and histamine release by immunological stimuli. 96
Generation of nitric oxide from nitrovasodilators modulates the release of histamine from mast cells. 94
COMPARAISON OF THE USEFULNESS OF DOPPLER-DERIVED DECELERATION TIME VERSUS PLASMA BRAIN NATRIURETIC PEPTIDE TO PREDICT LEFT VENTRICULAR REMODELING AFTER MECHANICAL REVASCULARIZATION IN PATIENTS WITH ST--ELEVATION ACUTE MYOCARDIAL INFARCTION AND LEFT VENTRICULAR SISTOLIC DYSFUNCTION 87
Evaluation of reference values for chromogranin A, pancreatic peptide and somatostatin 82
Design, synthesis and biological evaluation of nonpeptide integrin antagonists via Copper (I) Catalyzed Azide-Alkyne Cycloaddition 80
Cyclic DGR-peptidomimetic containing a bicyclic reverse turn inducer as a selective alphavbeta5 integrin ligand 75
Esperienza preliminare del nuovo dosaggio "whole PTH" nel monitoraggio intraoperatorio per iperparatiroidismo primario 73
Helycobacter pylori potentiates release histamines release indiced by bile acids from at serosal mast cells in vitro. 66
Helicobacter pylori potentiates histamine release from rat serial mast cells 63
Totale 3.688
Categoria #
all - tutte 8.989
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.989


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020318 0 0 0 0 0 61 49 66 59 32 38 13
2020/2021409 28 27 34 29 14 54 18 30 35 42 29 69
2021/2022219 7 21 21 14 10 10 8 10 10 12 46 50
2022/2023704 55 116 36 65 61 129 69 63 81 2 14 13
2023/2024197 10 21 26 7 12 40 13 34 2 7 16 9
2024/20251.021 34 139 91 212 406 139 0 0 0 0 0 0
Totale 3.688